Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Ride the Tiger with CD -- Ignore unavailable to you. Want to Upgrade?

To: Condor who wrote (161637)	5/30/2009 8:20:37 AM
From: robnhood	Respond to of 313272

I for one appreciate the good find of info, good or bad. I would rather be somewhat informed. Many times I have read bad news somewhere and dumped my stock only to watch it take off. You are correct IMO. This thread is for the sharing of info and if it goes against a recent favourite , well so be it.

To: Condor who wrote (161637)	5/30/2009 11:18:17 AM
From: Rocket Red	Read Replies (1) \| Respond to of 313272

Combined with expected results from testing at the NCI and with all previous test programs completed, we hope to see conclusive, independently derived proof of efficacy for PhG-alpha-1 that will attract the attention of both the pharmaceutical industry and the investment community in Canada and the United States." Really there burn rate is not big at all if you read the whole M&d you would see warrant had been exercised in there and i'll say it again there still getting exercised,thus putting money in gap. This is the Key independently derived proof of efficacy for PhG-alpha-1 that will attract the attention of both the pharmaceutical industry and the investment community in Canada and the United States."

To: Condor who wrote (161637)	5/30/2009 12:58:31 PM
From: Proud Deplorable	1 Recommendation Read Replies (1) \| Respond to of 313272

Even though I own some GAP too, I have to say that this company looks like it is closer to closing shop rather than making a miracle financial recovery based on research that will take years no doubt. Thanks for posting all of this. I lost some dough on GAP once and it looks like it might happen again. "Outlook PharmaGap expects to incur further losses from operations as it progresses through its development plan for its drug compounds. Based upon this and other factors discussed above there can be no assurances that the Company will continue as a going concern. The Company is actively seeking additional capital and seeking a business collaboration with other companies in the business of pharmaceutical development, including licensing arrangements and other business arrangements including but not limited to a sale of the Company or its assets, or a merger, or joint venture. Positive developments in the Company’s development could provide the potential for future issues of common stock. The Company has taken steps to reduce ongoing expenses by way of reductions in its workforce in order to allow it to focus on developmental testing while it pursues these business arrangements. These are forward looking statements and there can be no assurances that any of these will occur.